Key Patent Considerations for Antibody Drug Conjugates (ADCs)
By EsqSocial Corporation 09/04/25
In 1910, German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact with unique receptors on disease-causing cells while avoiding interaction with healthy cells....
By: Rothwell, Figg, Ernst & Manbeck, P.C.